Skip to main content
SpringerLink
Log in

Vulnerability and plasticity of monoamine neurotransmitter systems in affective and personality disorders

  • Chapter
Plasticity and Morphology of the Central Nervous System

Abstract

The monoamine neurotransmitter systems have attracted investigative interest in the last two decades for their putative role in the pathophysiology of two major DSM-III Axis I syndromes: the affective and schizophrenic disorders. The “catecholamine hypothesis” and the “dopamine hypothesis” of schizophrenia were based in part on some of the known pharmacologic effects of the antidepressants, e.g., catecholamine re-uptake antagonism, and the neuroleptics, e.g., dopamine receptor antagonism. Evidence supporting these hypotheses has not always been consistent, but has been sufficient to suggest some disturbances of the monoamine systems are associated with these DSM-III Axis I diagnosis, e.g., abnormalities of noradrenergic metabolite concentrations in the affective disorders and of dopaminergic metabolite concentrations in schizophrenia. More recent data suggests a “serotonergic hypothesis” of impulsivity/aggression, e.g., decreased serotonin metabolites in cerebrospinal fluid (CSF) of aggressive and suicide-attempting patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Foote, SL, Bloom, FE, Aston-Jones, G (1983). Nucleus locus coerulus: New evidence of anatomical and physiologic specificity. Physiol Rev 63, 844–914.

    PubMed  CAS  Google Scholar 

  2. Redmond, DE (1977). Alterations in the function of nucleus locus coeruleus: A possible model for studies of anxiety. In: Hanin, I and Usdin, E (eds.) Animal models in psychiatry and neurology.(New York: Pergamon Press )

    Google Scholar 

  3. Aston-Jones G, Bloom FE (). Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced resonses to non-noxious environmental stimuli.

    Google Scholar 

  4. Weiss JM, Bailey WH, Goodman PA, et al (1982). A model for neurochemical study of depression. In: Levy, A, and Spiegelstein, MV (eds.) Behavioral models and the analysis of drug action. ( Amsterdam: Elsevier )

    Google Scholar 

  5. Ellinwood, EH. Sudilovsky, A, Nelson, LM (1973). Evolving behavior in the clinical and experimental (model) psychosis. Am J Psychiatry 130, 1088–1093.

    PubMed  Google Scholar 

  6. Weinberger, DR (1987). Implications of normal brain development for the pathogeneis of schizophrenia. Arch Gen Psychiatry 44, 660–670.

    PubMed  CAS  Google Scholar 

  7. Mathysse, S (1978). Missing links. In: Wynne, RC, Cromwell, RL, Mathysse, S (eds.). “The Nature of schizophrenia”. pp. 148–150. ( New York: Wiley & Sons )

    Google Scholar 

  8. Valzelli, L (1981). Psychobiology of aggression and violence. ( New York: Raven Press )

    Google Scholar 

  9. Gray, JA (1982). The Neuroendocrinology of anxiety. An enquiry into the function of the septo-hippocampal system. ( Oxford: Oxford University PRess )

    Google Scholar 

  10. Kendler, KS, Gruenberg, AM, Strauss, JJ (1981). An independent analysis of the Copenhagen sample of the Danish Adoption Study of Schizophrenia: II. The relationship between schizotypal personality disorders and schizophrenia. Arch Gen Psychiatry 38, 982–984.

    PubMed  CAS  Google Scholar 

  11. Siever, LJ (1982). Genetic factors in borderline personality disorder. In: Grinspoon, L (ed.) American Psychiatric Review. pp. 437–456. ( Washington, D.C.: American Psych Press )

    Google Scholar 

  12. Cloninger, CR (1978). The link between hysteria and sociopathy: An integrative model of pathogenesis based on clinical, genetic, and neurophysiological observations. In: Akiskal, HS, Webb, WL (eds.) Psychiatric Diagnosis Exploration of Biological Predictors. ( New York: Spectrum Publishers )

    Google Scholar 

  13. Goldstein, JL and Brown, MS (1985). Familial hypercholesterolemia: A genetic receptor disease. Hospital Practice 20, 35–41, 45–6.

    Google Scholar 

  14. Kolterman, OG, Scarlett, JA, Olefsky, JM (1982). Insulin resistance in non-insulin-dependent, type II diabetes mellitus. Clin Endocrinol Metab 11, 363–388.

    Article  PubMed  CAS  Google Scholar 

  15. Siever LJ, Davis KL (1985). Overview towards a dysregulation model of depression. Am J Psychiatry 142, 1017.

    PubMed  CAS  Google Scholar 

  16. Siever LJ, Uhde, TW. New studies and perspectives on the noradrenergic rceptor system in depression: Effects of the alpha2-adrenergic agonist clonidine. Biol Psychiatryl9, 131–156.

    Google Scholar 

  17. Spitzer, RL, Endicott, J (1978). Schedule for affective disorders and schizophrenia. New York, New York State Psychiatric Institute.

    Google Scholar 

  18. Creese, L, Burt, DR, Snyder, SH (1976). Dopamine receptor binding predicts clinical and pharmacologic potencies of antischizophrenic drugs. Science 192, 481–483.

    Article  PubMed  CAS  Google Scholar 

  19. Pickar, D, Sweeney, DR, Maas, JW et al (1978). Primary affective disorder, clinical state change and MHPG excretion: A longitudintal study. Arch Gen Psychiatry 35, 1378–1383.

    PubMed  CAS  Google Scholar 

  20. Davis, KL, Davidson, M, Mohs, RC (1985). Plamsa homovanillic acid concentration and the severity of schizophrenic illness. Science 227, 1601–1602.

    Article  PubMed  CAS  Google Scholar 

  21. Kendler, KS, Masterson, CC, Ungaro, R, et al (1984). A family history study of schizophrenia-related personality disorders. Am J Psychiatry 141, 424–427.

    PubMed  CAS  Google Scholar 

  22. Torgersen, S (1985). Relationship of schizotypal personality disorder to schizophrehnia: Genetics. Schizophrenia Bull 11 (4), 554–563.

    CAS  Google Scholar 

  23. Siever, LJ (1985). Biological markers in schizotypal personality disorder. Schizophrenia Bull 11 (4), 564–575.

    CAS  Google Scholar 

  24. McGlashan, TH (1986). Schizotypal personality disorder. Chestnut Lodge Follow-up study: IV. Long-term follow-up pespectives. Arch Gen Psychiatry 43, 329–334.

    PubMed  CAS  Google Scholar 

  25. Serban, G, Siegel, S (1984). Response to borderline and schizotypal patients to small doses of thiothixene and haloperidol. Am J Psychiatry 141, 1455–1458.

    PubMed  CAS  Google Scholar 

  26. Goldberg, SC, Schultz, SC, Schultz, PM (1986). Borderline and schizotypal personality disorders treated with low-dose thiothixene vs. placebo. Arch Gen Psychiatry 43, 680–686.

    PubMed  CAS  Google Scholar 

  27. Van Kamen, DP Steinberg, DE (1980). Cerebrospinal fluid studies in schizophenia. In Woods, JH (ed.) Neurobiology of cerebrospinal acid I. pp. 719–742. ( Plenum Press: New York )

    Google Scholar 

  28. Post RM, Fink, E, Carpenter, WT et al (1975). Cerebrospinal fluid amine metabolites in acute schizophrenia. Arch Gen Psychiatry 32: 1063–1070.

    PubMed  CAS  Google Scholar 

  29. Rimon, R, Roos, BG, Rakkolainan, Y (1971). The content of 5-HIAA and HVA in CSF of patients with acute schizophrenia. J Psychom Res 15, 375–378.

    Article  CAS  Google Scholar 

  30. Lindstrom, LH (1985). Low HVA and normal 5-HIAA CSF levels in drug free schizophrenic patients compared to healthy volunteers: Correlations to sympatology and family history. Psych Res 14, 265–273.

    Article  CAS  Google Scholar 

  31. Stangl, D, Pfohl, B, Zimmerman, M, et al (1985). A structured interview for the DSM-III personality disorders. Arch Gen Psychiatry 42, 591–596.

    PubMed  CAS  Google Scholar 

  32. Chapman, SJ, Edell, WS, Chapman, JP (1980). Physical anhedonia, perceptual aberration, and psychosis proneness. Schizophrenia Bull 6, 640–653.

    Google Scholar 

  33. Spielburger, C, Gorsuch, R, Lushene, R (1970). Manual for the state-trait anxiety inventory. ( Consulting Psychologists Press: Palo Alto )

    Google Scholar 

  34. Buss, AH, Durkee, A (1957). An inventory for assessing different kinds of hostility. Journal of Consulting Psychology 21, 343–348.

    Article  PubMed  CAS  Google Scholar 

  35. Davidson, M, Giordani, A, Mohs, RC, et al (1987). Control of extraneous factors affecting plasma homovanillic acid concentrations. Psychiatry Res 20, 307–312.

    Article  PubMed  CAS  Google Scholar 

  36. Karoum, F, Karson, CN, Bigelow, LB et al (1987). Preliminary evidence of reduced combined output of dopamine and its metabolites in chronic schizophrenia. Arch Gen Psychiatry 44, 604–607.

    PubMed  CAS  Google Scholar 

  37. Asberg, M., Traskman, L., Thoren, P. 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor? Arch Gen Psychiatry 1976; 33: 1193–1197

    PubMed  CAS  Google Scholar 

  38. Agren, H (1980). Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: II. Suicide patterns. Psychiatry Res 3, 225–236.

    Article  PubMed  CAS  Google Scholar 

  39. Traskman, L, Asberg, M, Bertilsson, L, et al (1981). Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38, 631–636.

    PubMed  CAS  Google Scholar 

  40. van Praag, HM (1982). Depression, suicide and the metabolism of serotonin in the brain. J Affective Disord 4, 275–290.

    Article  Google Scholar 

  41. van Praag, HM (1983). CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet ii: 977–978.

    Article  Google Scholar 

  42. Ninan, PT, van Kammen, DP, Scheinen, M, et al (1984). Cerebrospinal fluid 5-HIAA in suicidal schizophrenic patients.Am J Psychiatry 141, 566–569.

    PubMed  CAS  Google Scholar 

  43. Brown, GL, Goodwin, FK, Ballenger, JC, et al (1979). Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1, 131–139.

    Article  PubMed  CAS  Google Scholar 

  44. Brown, GL, Ebert, MH, Goyer, PF, et al (1982). Aggression, suicide and serotonin: Relationships to CSF amine metabolites. Am J Psychiatry 139, 741–746.

    PubMed  CAS  Google Scholar 

  45. Linnoila, M, Virkkunen, M, Scheinin, M, et al (1983). Low cerebrospinal fluid 5-hydroxyindolacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 33, 2609–2614.

    Article  PubMed  CAS  Google Scholar 

  46. Lidberg, L, Tuck, JR, Asberg, M, et al (1985). Homicide, suicide and CSF 5-HIAA. Acta Psychiatr Scand 71, 230–236.

    Article  PubMed  CAS  Google Scholar 

  47. Stanley, M, Viggilio, J, Gershon, S, et al (1982). Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216, 1337–1339.

    Article  PubMed  CAS  Google Scholar 

  48. Paul, SM, Rehavi, M, Skolnick, P, et al (1984). High affinity binding of antidepressants to a biogenic amine transport in human brain and platelet: studies in depression. In Post, RM and Ballenger, JC (eds.). Neurobiology of Mood Disorders pp. 845–953. Baltimore, Williams & Wilkins.

    Google Scholar 

  49. Stanley, M, Mann, JJ (1983). Increased serotonin- 2 binding sites in frontal cortex of suicide victims. Lancet 1, 214–216.

    Article  PubMed  CAS  Google Scholar 

  50. Meltzer, HY, Perline, R, Tricou, BJ, et al (1984). Effect of 5-Hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis, and depressive symptoms. Arch Gen Psychiatry 41, 379–387.

    PubMed  CAS  Google Scholar 

  51. Siever, LJ, Murphy, DL, Slater, S, et al (1984). Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sci 34, 1029–1039, 1984.

    Article  PubMed  CAS  Google Scholar 

  52. Davis, BM, Mathe, AA, Mohs, RC, et al (1983). Effects of probantheline bromide on basal growth hormone, cortisol, and prolactin levels. Psychoneuroendocrinoloqv 8, 103–107.

    Article  CAS  Google Scholar 

  53. Buss, AH, Durkee, A (1957). An inventory for assessing different kinds of hostility. J Consult Psvchol 21, 343–348.

    CAS  Google Scholar 

  54. Lanyon, RL (1961). A Handbook of MMPI Profiles, Minneapolis, University of Minnesota Press.

    Google Scholar 

  55. Barratt, ES (1965). Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychol Reports 16, 548–554.

    Google Scholar 

  56. Siever, LJ, Klar, H, Coccaro, EF (1985). Psychobiologic Substrates of personality. In: Klar, H, Siever, LJ (eds). Biologic Response Styles: Clinical Implications, American Psyciatric Press, Inc., pp. 37–66.

    Google Scholar 

  57. Sheard, MH, Marini, JL, Bridges, CI (1976). The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry 133, 1409–1413.

    PubMed  CAS  Google Scholar 

  58. Meyendorff, E, Jain, A, Traksman-Bendz, et al (1986). The effects of fenfluramine on suicidal behavior. Psychopharm Bull 22, 155–159.

    CAS  Google Scholar 

Download references

Authors
  1. L. J. Siever
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. F. Coccaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Davidson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Harter
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. L. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Istituto di Clinica Psichiatrica, Università degli Studi di Milano, Milan, Italy

    C. L. Cazzullo , E. Sacchetti , G. Conte , G. Invernizzi  & A. Vita , , ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Siever, L.J., Coccaro, E.F., Davidson, M., Howard, L., Harter, L., Davis, K.L. (1990). Vulnerability and plasticity of monoamine neurotransmitter systems in affective and personality disorders. In: Cazzullo, C.L., Sacchetti, E., Conte, G., Invernizzi, G., Vita, A. (eds) Plasticity and Morphology of the Central Nervous System. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0851-2_23

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0851-2_23

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6870-3

  • Online ISBN: 978-94-009-0851-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation